Home
About
Publications Trends
Recent Publications
Expert Search
Archive
interphone study
What is the Interphone Study?
The
Interphone Study
is a significant international research project that investigated the potential link between
mobile phone use
and the risk of developing certain types of
brain cancer
. Initiated in 2000, it involved researchers from 13 countries and was coordinated by the
International Agency for Research on Cancer (IARC)
, a part of the World Health Organization (WHO).
Frequently asked queries:
What is the Interphone Study?
What Types of Cancer Were Investigated?
How Was the Study Conducted?
What Were the Key Findings?
What Has Been the Impact of the Study?
What Are the Recommendations for Mobile Phone Users?
What Types of Support Are Available for Cancer Patients?
How to Identify Sponsored Content?
How Do Claims Work in Cancer Insurance?
Which Cancers are Associated with RTK Dysregulation?
Can CHF be Prevented in Cancer Patients?
What Are the Benefits of International Collaboration?
How important is regular screening in cancer prevention?
How Can Time-Consuming Treatments Affect Prognosis?
What are the Benefits of Recertification?
What are the Key Steps in a Co-Immunoprecipitation Experiment?
Why Is Communication Important for Oncology Nurses?
What Role Do Inherited Mutations Play?
Why Are Proofreading and Repair Mechanisms Important?
How Do Researchers Study Network Dynamics?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe